Hollis Salzman is Co-Chair of the Firm’s Antitrust Practice Group. She represents clients in cases involving federal antitrust law violations. Her work in the area of antitrust law has been recognized by the National Law Journal. She is also involved in the Firm’s securities litigation practice group where she represents institutional investors in portfolio monitoring and securities litigation. Some of Ms. Salzman’s clients include MARTA and the City of Macon, Georgia.

Ms. Salzman is actively engaged in the prosecution of major antitrust class actions pending throughout the United States. She is presently Co-Lead Counsel in many antitrust cases, including: In re Air Cargo Shipping Services Antitrust Litigation, In re Marine Hoses Antitrust Litigation, In re Puerto Rican Cabotage Antitrust Litigation, and In re Florida Cement & Concrete Antitrust Litigation.

She serves as Co-Lead Counsel in several antitrust class actions which resulted in extraordinary settlements for class members in In re Air Cargo Shipping Services Antitrust Litigation ($85 million partial settlement from certain defendants); In re Marine Hose Antitrust Litigation ($27 million partial settlement); In re Puerto Rican Cabotage Antitrust Litigation ($33.5 million partial settlement); In re Abbott Labs Norvir Antitrust Litigation ($10 million settlement); In re Buspirone Antitrust Litigation ($90 million settlement); In re Lorazepam & Clorazepate Antitrust Litigation ($135.4 million settlement) and In re Maltol Antitrust Litigation, and Continental Seasonings Inc. v. Pfizer, Inc., et al., ($18.45 million settlement). Additionally, she was principally responsible for administering a $65 million settlement with certain brand-name prescription drug manufacturers where their conduct allegedly caused retail pharmacy customers to overpay for their prescription drugs.

Ms. Salzman is the co-author of the following articles: "NFL: Single Entity or Sherman Act Violator?," New York Law Journal, March 8, 2010; “Iqbal And The Twombly Pleading Standard,” CompLaw 360, June 15, 2009; “Analysis of Abbott Laboratories Antitrust Litigation,” Pharmaceutical Law & Industry Report, June 20, 2008; and “The State of State Antitrust Enforcement,” NYSBA NYLitigator, Winter 2003, Vol. 8, No. 1.

She is a Co-Chair of the New York State Bar Association, Commercial & Federal Litigation Section – Antitrust Committee, and a member of the Association of the Bar of the City of New York Antitrust Committee and Women’s Antitrust Bar Association. Ms. Salzman also provides pro bono representation to indigent and working-poor women in matrimonial and family law matters.